Branded Formulations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eris acquires 51 pc stake in Swiss Parenterals for Rs 637 5 cr

Eris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parenterals is a leading player in the sterile injectables business in over 80 emerging markets across Africa, the Asia Pacific and Latin America.

Business newsBreaking newsbudgetLatest news updatesEconomic timesEconomic times news appDaily market updatesLive businessEris lifesciencesSwiss parenteralsSwiss parenterals ltdBranded formulationsMd amit bakshiLatin americaAsia pacific

Biocon Biologics announces divestment

Biocon Biologics Limited , a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON), today announced that it has entered into a definitive agreement with Eris Lifesciences (Eris) for the divesture of its Dermatology and Nephrology branded formulations business units in India that mostly comprised of its legacy small molecules’ brands. The transaction is a

Shreehas tambeBiocon biologicsAmit bakshiEris lifesciences ltdBiocon limitedBiocon biologics limitedEris lifesciencesSlump saleBranded formulationsManaging directorBiocon biologic nephrologyDermatology branded formulations

Eris Lifesciences acquires two businesses from Biocon arm

Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase Biocon Biologics Ltd’s dermatology and ..

Amit bakshiShreehas tambeAman rawatBiocon biologicsKuwait investment authorityBiocon biologics ltdEris lifesciences ltdBombay stock exchangeEris lifesciencesLifesciences ltdBombay stockStrides shasunOaknet healthcareBiocon biologicBranded formulationsSubscribe now

Biocon Biologics divests two non-core branded formulations to Eris for Rs 366 Cr

Biocon Biologics divests two non-core branded formulations to Eris for Rs 366 Cr
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Biocon biologicsShreehas tambeAmit bakshiEris lifesciences ltdEris lifesciencesSlump saleBiocon biologicBranded formulationsManaging directorBiocon biologic nephrologyDermatology branded formulations

Eris acquires nephrology, dermatology brands of Biocon for Rs 366 crore

The deal will be funded partly through debt financing. The transaction is expected to achieve financial closure by the end of 2023.

Amit bakshiShreehas tambeBiocon biologicsBiocon biologics ltdEris lifesciences ltdBranded formulation indiaChronic kidney diseaseBiocon biologic nephrologyManaging directorEris lifesciencesMedical dermatologyOrgan transplantsBranded formulationsBiocon biologics limitedEris lifesciences